Edit: Commenter David Green below reports that he has been to one of these conferences, and that it is not a scam. I can’t confirm this personally, but will correct myself if I’m shown to be wrong. My suspicions were raised based on word of mouth, but also by the fact that the friends who received this email at the time were first-year graduate students (i.e., clearly not leaders in their field). That plus the non-native English raised red flags. If anyone else knows about these conferences firsthand, please tell me about it in the comments.
A couple of friends just received the following email, inviting them to a marine biotechnology conference in China this spring. Turns out it’s a scam: this company makes up all kinds of fake conferences in different scientific fields. When you register, they steal your credit card. So don’t register.
It’s actually kind of amazing how believable this looks at first glance: the sessions are all on real topics, and they have a professional-looking website. I wonder, now that people know to be wary of Nigerian princes trying to give away their fortunes, if email phishing is headed in this direction—i.e., more sophisticated and targeted.
The original email is below:
BIT’s 1st Annual World Congress of Marine Biotechnology (WCMB-2011)
Time: April 25-29, 2011
Place: Dalian, China
Website: http://www.bitlifesciences.com/wcmb2011/Dear [your name here],
We would like to extend our invitation to you to be a speaker at our upcoming event: BIT’s 1st Annual World Congress of Marine Biotechnology (WCMB-2011) which will help to bring together scientists, managers, faculties, decision makers among all organizations engaged in marine biotechnology and encourage the development of commercialization of marine biotechnology. As we know your work in this field is a clear example of the leadership, so we would like to highlight your effort at our conference which will take place during April 25-29, 2011 in Dalian, China, with the theme of “Ocean, Life and Sustainability”. We express our sincere wish for your participation in this conference and make an oral presentation at one session of Track 1: Breaking R & D in Marine Biotechnology, The details of the sessions are:
Track 1-1: Marine Molecular/Cell Biology and Physiology
Track 1-2: Marine Ecology and Microbiology
Track 1-3: Marine Organismal Molecular Biology & Biotechnology
Track 1-4: Genomics, Proteomics & Metabolomics in Marine Biotechnology
Track 1-5: Marine Metagenomics and Bioinformatics
Track 1-6: The Marine Biotechnology Research Toolkit
Track 1-7: Marine Extremophiles
Track 1-8: Marine Nanobiotechnology and Biomaterials
Track 1-9: Sustainable Aquaculture and Fishery
Track 1-10: Conservation, Bioinvasion and Climate ChangeWCMB-2011 will take the form of plenary lectures, oral presentations, posters, exhibitions and project matchmaking; it covers topics from breakthroughs in Marine Biotechnology R & D, Algal Biotechnology, Marine Natural Products and Valuable Materials, Marine Bioenergy and Engineering, Marine Resources and Environment Bioremediation to applications of Marine biotechnology. WCMB-2011 will provide an ideal platform for marine biotechnologist to debate and deliberate on issues that are critical for the progress of this emerging area and identify the challenges and opportunities for the development of Marine Biotechnology.
Your participation as a speaker at this year’s world congress would add great value for your organization and our attendees. Please contact Ms. Doris Han at doris@bit-ibio.com if you are able to participate. Thank you for your timely consideration of this invitation, and we look forward to hearing from you soon.
In addition, this major international event will be held in Dalian, one of the most beautiful coastal cities. After the conference, you are welcomed to join the Tech tour to experience the traditional Chinese culture and enjoy the delicious food in China.
The details of the conference, please visit: http://www.bitlifesciences.com/wcmb2011/
Best Regards,
Ms. Doris Han
Organizing Committee of WCMB-2011
26 Gaoneng St., F4
Dalian Hightech Zone
Dalian, LN 116025, China
Tel: 0086-411-84799609 ext 813
Fax: 0086-411-84799629
Email: doris@bit-ibio.comPS: We expect your precious comments or suggestions on the structure of our program, also your reference to other speakers will be highly appreciated. We look forward to receiving your replies on the following questions.
1. Are you interested in delivering a speech in one of these sessions? Which session?
2. What is the title of your speech?
3. Do you want to co-organize one of the sessions or have any suggestions about our scientific program?
Full Program
Track 1: Breaking R & D in Marine Biotechnology
Track 1-1: Marine Molecular/Cell Biology and Physiology
Track 1-2: Marine Ecology and Microbiology
Track 1-3: Marine Organismal Molecular Biology & Biotechnology
Track 1-4: Genomics, Proteomics & Metabolomics in Marine Biotechnology
Track 1-5: Marine Metagenomics and Bioinformatics
Track 1-6: The Marine Biotechnology Research Toolkit
Track 1-7: Marine Extremophiles
Track 1-8: Marine Nanobiotechnology and Biomaterials
Track 1-9: Sustainable Aquaculture and Fishery
Track 1-10: Conservation, Bioinvasion and Climate ChangeTrack 2: Algal Biotechnology and Phycology
Track 2-1: Algae Ecology, Cell Biology, Biochemistry, and Systematics?
Track 2-2: Algae and Cyanobacteria in Extreme Environments
Track 2-3: Micro-algal Biotechnology
Track 2-4: Algal Cultivation Techniques toward Seaweed Farming and Aquaculture
Track 2-5: Biotechnology Improving Algal Production & Productivity
Track 2-6: Algae Photobioteactors
Track 2-7: Robust Algal Processing & Downstream Production
Track 2-8: Algae in Health, Nutrition, Cosmetic and Feed Industries
Track 2-9: Harmful Algae Blooms and Green Tide
Track 2-10: Applications of Algae in Wastewater Treatment, Carbon Capture & RecycleTrack 3: Marine Natural Products and Valuable Materials
Track 3-1: Resources, Isolation and Identification of Bioactive Marine Natural Products
Track 3-2: Marine Chemistry of Natural Products
Track 3-3: Eicosanoids from Algae
Track 3-4: Marine Peptide and Protein and its Functions
Track 3-5: Marine Microalgae Polysaccharides
Track 3-6: Marine Enzymes with Unique Functions
Track 3-7: Natural Products and Materials from Sponges
Track 3-8: Marine Biopolymers and Applications
Track 3-9: Materials in Preventing Marine Corrosion
Track 3-10: Novel Composite Materials for Marine ApplicationsTrack 4: Biomedical Applications of Marine Biotechnology
Track 4-1: New Drug Screening from Marine Microorganism Metabolites
Track 4-2: Discovery of Marine Biomarker, and Biological Active Compounds
Track 4-3: Marine Products for Biomedical Assay
Track 4-4: Anticoagulant and Anti-thrombic Marine Products
Track 4-5: Antiviral and Antibacterial Marine Natural Products
Track 4-6: Anti-Tumor, Anti-metastatic Marine Natural Products
Track 4-7: Other Biomedical Applications of Marine BiotechnologyTrack 5: Marine Bioenergy and Engineering
Track 5-1: Algae and Seaweed Biomass
Track 5-2: Marine Bioethanol
Track 5-3: Marine Biodiesel
Track 5-4: Marine Biogases
Track 5-5: Algal Biofuels CommercializationTrack 6: Marine Resources and Environment Bioremediation
Track 6-1: Metagenomics and Synthetic Genomics for New Marine Resources
Track 6-2: Marine Industry Processes and Products
Track 6-3: Bioremediation for Bacterial Biofilms and Biofouling
Track 6-4: Bioremediation for Spilled Oils on the Sea
Track 6-5: Novel Marine Biotechnology for Conservations and Environment ProtectionsTrack 7: Business Forum on Marine Biotechnology
-5 Open Sessions for Free Organizations by both Tech and Product Suppliers and Investors
-Open Space for Interactive Forum (please propose)
Scary! Here is a video about the inner life of the cell. If you haven’t seen this it is definitely worth a look. http://www.americanbiotechnologist.com/blog/a-molecular-biology-video-classic/
I have attended one of the conferences organized by this company in Beijing China from 23rd to 26th October this year, it was a great conference. I have received similar email early this year, and I have registered through the online process, it was fine. I have delivered my speech successfully, and most importantly, I met few people who are interested in our research. I am happy to attend the latest conference.
I contributed to just one scientific paper until now and got a similar email:
———————————
Dear Dr. Amanjit Gill,
How are you?
I was wondering if there is some technical problem in my email box. I did not receive your reply until now. We apologize if you received the letter more than once. We sincerely invite you to give a speech at Track 2-5: Neuro-Oncology of BIT Life Sciences’ 4th World Cancer Congress (WCC-2011). Will you be available at that time? It will be honor for us to have your attendance. We appreciate that you offer us a potential speech title if it is convenient. Below is a formal invitation letter to you.
BIT’s 4th World Cancer Congress 2011
Time: May 22-25, 2011
Venue: World EXPO Center, Dalian, China
Theme: Collaborative Actions against Cancer
Website: http://www.bitlifesciences.com/cancer2011/
Dear Dr. Amanjit Gill,
Based upon your great contributions to the field of oncology, the organizing committee cordially invites you to give a speech at Track 2-5: Neuro-Oncology of BIT Life Sciences’ 4th World Cancer Congress (WCC-2011). The theme of the conference is Collaborative Actions against Cancer, and it will be held from May 22 to May 25, 2011 in Dalian, China.
The World Cancer Congress has been held successfully the past three years in Shanghai, Beijing and Singapore respectively, and has attracted over 600 eminent speakers and 1000 participants each time. The fourth congress promises to be an even greater event that will emphasize practical and advanced ideas for accelerating cancer research and therapy.
Some of the renowned speakers who have confirmed their participation in the event include:
Dr. Isaac Djerassi, Winner of the 1972 Lasker Clinical Medical Research Award; Professor, Mercy Catholic Medical Center, USA
Dr. Michael Sela, Institute Professor of Immunology, Past President, Weizmann Institute of Science, Israel
Dr. Paul W. H. I. Parren, Scientific Director and Senior Vice President, Genmab, Netherlands
Dr. Peter P. Chou, Director of Scientific Affairs, Quest Diagnostics Nichols Institute, USA
Dr. Moshe Szyf, Professor, Director, Department of Pharmacology and Therapeutics, McGill University, Canada
The conference will consist of 10 scientific tracks, panel discussions, poster presentations, and an exhibition. Through these activities we hope to provide participants with a platform for discussing the latest issues facing the field of oncology, and many opportunities for networking and forming new partnerships.
We look forward to seeing you in Dalian in 2011 for this influential event.
For more information, please visit the conference website at http://www.bitlifesciences.com/cancer2011/.
Sincerely yours,
Nancy Shao,
Program Coordinator
Organizing Committee of WCC-2011
26 Gaoneng St., F4
Dalian Hightech Zone
Dalian, LN 116025, China
Tel: 0086-411-84799609-821
Fax: 0086-411-84799629
Email: nancy@cancercon.com
Website at: http://www.bitlifesciences.com/cancer2011/
———————————
‘Dave’,
Good try – your english is almost perfect – your response is just part of this scam. Real conferences don’t work like this. Its a pity only a few people were interested in your research.
I am also received the similar kind of email as followed
Dear Siva,
We just want to deliver our warmest regards and hope you can advise your opinion in participation to our meeting BIT’s 1st Annual World Congress of Marine Biotechnology （WCMB-2011） as a speaker. We wonder your silence to several invitations from us previously, but some news below may benefit your attention.
So far, we have invited 10 Nobel Prize Laureates and they have confirmed their participation already. Since April 25th to 30th, you will enjoy one Nobelist Forum for each day. Sincerely hope you can cherish this valuable chance to have a communication with so many Nobel Prize winners also renowned audiences and attendees from academy to industry.
We really appreciate any consultation in WCMB-2011 from you!
Best Regards,
Ms. Doris Han
Organizing Committee of WCMB-2011
26 Gaoneng St., F4
Dalian Hightech Zone
Dalian, LN 116025, China
Tel: 0086-411-84799609 ext 833
Fax: 0086-411-84796898
Email: doris@bit-ibio.com
I was also invited to this conference, and at first I was suspicuous too (for many reasons) and eventually decided not to go (for other reasons). However, if the company is a scam – I must say that they put a lot of work into the scam. They even publish photographs and websites from previous conferences they have organised (scammed?) …..
I have been fooled (once) by a booking company on the web. However, completely different approach – no personal contacts, no functioning telephone numbers on the website, website up for a short period, no secure way of paying.
For those thinking of attending the conference and want to reduce risk – try the telephone numbers, check with the hotels they suggest. If anything shady, contact Chinese authorities if possible. I don´t think this kind of scam will go down well in China.
And to MLM about your comment to Dave – please accept that all people do not have English as their first language, which by definition does not make them part of this (possible) scam. I had no problem to understand what Dave meant by “a few people whoa are interested in my research”.
Hey Dave, just thought I’d help you role play a native English speaker:
I
haveattended one of the conferences organized by this company in Beijing, China from 23rd to 26th October this year,. It was a great conference. Ihavereceived a similar email early this year and Ihaveregisteredthrough theonlineprocess, it was fine. Ihavedelivered my speech successfully, and most importantly, I met a few people who are interested in our research. I amhappyplanning to attend thelatestupcoming conference.Please put me up in a room in one of your many lovely hotels as described on your various websites.
Hi everyone and thanx for your warnings!
I guess a lot of young researchers feel flattered when being invited as a speaker…
Website looks quite professional, but prices are high…
Here the latest fake-email:
The 1st World congress of Environmental Biotechnology-2011 (WCEB-2011)
Theme: Healthier, Safer, and Environment Friendly
Time: October 19-22, 2011
Venue: Dalian, China
Website: http://bitconferences.com/wceb2011/
—————————————————————————————————————————-
Dear Dr. M. Majewsky,
We are proud to announce that the World Congress of Environmental Biotechnology-2011 (WCEB-2011) with a theme of “Healthier, Safer, and Environment Friendly” will be held during October 19-22, 2011 at World Expo Center, Dalian, China. Now we’re calling for experts in the area of Environmental Biotechnology to make experience exchanges around the world. On behalf of the organizing committee, we’re pleased to welcome you to offer a speech at Section 5-12: Active Sludge Modeling and Processes.
(Session details PS: http://www.bitconferences.com/wceb2011/tech_program.asp )
As you know, environmental biotechnology is currently experiencing a dramatic increasing; it has become a key element of the interactions between nature and society and is considered a key input for environmental biotechnology development. This focused event pays tribute to the growing significance of environmental biotechnology. For these reasons, we are fully committed to organizing a world-class program to initiate a sustainable platform for exchanging up-to the minute upstream and downstream achievements, industrial needs and research opportunities of environmental biotechnology fields in Asia Pacific Rim.
WCEB-2011 will bring more than 400 world-class scientists, engineers and educators engaged in the fields of Environmental Biotechnology to meet and present their latest activities. This will be a platform for open debate, discussion, proposals of practical and evidence-based solutions. We also hope WCEB-2011 can meet the challenges and demands by related societies to help developing new strategies and methodologies under international standard to support climate change control.
It is up to all of you to make of our 1st Annual World Congress of Environmental Biotechnology a memorable meeting. Dalian, as the most beautiful coastal city in northern China, is keen on making great efforts on improving living environment to the mitigation of climate change. Welcome to Dalian and enjoy your stay in one of the most beautiful and attractive city!
For more information, please see: http://www.bitconferences.com/wceb2011/ . It will be highly appreciated if you could answer the following questions:
1. Would you like to join us as a Science Advisory Broad member?
2. What topic would like to talk about at our conference? Could you please forward us a speech title and a brief introduction to the topic?
3. Do you have any suggestions about our scientific program or want to chair/ co-organize one of the sessions?
We are looking forward to seeing you in Dalian, 2011.
Best Regards,
Ms. Betty Chen
Program Coordinator
Organizing Committee of the WCEB-2011
26 Gaoneng St., R405, Dalian Hightech Zone
Dalian , LN 116025, China
Tel: 0086-411-84799609-813
Fax: 0086-411-84799629
Email: betty@bitpetrobio.cn
————————————————————————————————————————-
Program
Opening Ceremony and Keynote Forum
Chapter 1: Environmental Bioscience
Section 1-1: Environmental Pollution, Law and Public Health
Section 1-2: Molecular Microbial Ecology for a Better Environmental Control
Section 1-3: Environmental Molecular Cell Biology
Section 1-4: Toxicology and Bio-Assessment
Section 1-5: Genetics and Environmental Microbes
Section 1-6: Environmental Microbiology and Microbial Bioengineering
Section 1-7: Plant, Crop Biotechnology and Environmental Management
Section 1-8: Animal, Aquatic Biotechnology and Environment Management
Section 1-9: Environmental Biochemistry and Biophysics
Section 1-10: Environmental Genomics and Proteomics
Section 1-11: Metagenomics and Soil Microbiology
Section 1-12: Marine Metagenomics and Environment Protection
Section 1-13: Geomicrobiology and Environment Protection
Section 1-14: Phytotechnology for Environment Management
Section 1-15: Biodiversity Conservation, Mapping and Management
Chapter 2: Leading Technology in Environmental Biotechnology
Section 2-1: Miniaturization of Robust Devices for COD and BOD Assays
Section 2-2: Bioinformatics and Environmental Biotechnology
Section 2-3: Microbe Immobilization Technology
Section 2-4: Environmental Biomarkers
Section 2-5: Biochips and Microarrays in Environmental Biotechnology
Section 2-6: Biosensors and Environmental Biotechnology
Section 2-7: Biofilm Reactors and Membrane Technologies
Section 2-8: Nanobiotechnology and Environmental Engineering
Section 2-9: DNA Gene Probes and PCR Technology
Section 2-10: Immunoassay and Bioluminascent Technology
Section 2-11: GIS, Statistics, and Remote Sensing
Section 2-12: A/O Phosphorus Removal Biotechnology
Section 2-13: Biogranulation Technologies for Wastewater Treatment
Section 2-14: Environmental Isotopes in Bioremediation and Biodegradation
Section 2-15: Biotechnology for Carbon Capture and Storage
Section 2-16: Microbial Solid-State Cultivation Process and Bioreactors
Section 2-17: Anaerobic Digestion in Suspended Growth Bioreactors
Section 2-18: Areobic and Anoxic Suspended-Growth Biotechnology
Section 2-19: Aerobic and Anaerobic Attached-Growth Biotechnology
Section 2-20: Floating Biological Systems
Chapter 3: Environmental Biotech for Industrial Wastes
Section 3-1: Outlook of Environmental Biotechnology and Bioremediation under Law
Section 3-2: Selection and Design of Bioreactors for Environmental Bio-engineering
Section 3-3: System for Industrial Wastes
Section 3-4: Antibiotic Industrial Wastes
Section 3-5: Pharmaceutical Wastes
Section 3-6: Soap and Detergent Wastes
Section 3-7: Pulp and Paper Mill Wastes
Section 3-8: Textile and Leather Wastes
Section 3-9: Phosphate Industrial Wastes
Section 3-10: Pesticide Industrial Wastes
Section 3-11: Rubber Industrial Wastes
Section 3-12: Power Industrial Wastes
Section 3-13: Tanning Industry Wastes
Section 3-14: Chemical Industry Organic Wastes
Section 3-15: Painting, Coating and Lubricant Industrial Wastes
Section 3-16: Starch Factory Wastes
Section 3-17: Cellulose Waste Pollution from Sugar Industry
Section 3-18: Food Processing Wastewater
Section 3-19: Fruit Juice, Beverage and Wine Industrial Wastes
Section 3-20: Dairy Industrial Wastes
Section 3-21: Aquaculture Wastes
Section 3-22: Wastes from Vegetable Oil and Shortening Production
Section 3-23: Decolorized Bacterial Strains for Dye Industry Wastes
Section 3-24: Biological Degradation of Phenol and Anilne Residues
Section 3-25: Sulfate-riched Industrial Wastes
Section 3-26: Nitrogen-riched Industrial Wastes
Section 3-27: Electronics Recycling and E-Wastes
Section 3-28: Biodegradation of Chlorinated Compounds
Section 3-29: Biodegradation of Ammonium Perchlorate Wastes
Section 3-30: Removal of Metal Ions from Aqueous Solutions
Section 3-31: Biosorbents for Reactive Dyes and Heavy Metal Ions
Section 3-32: Microbial Model for the Management of Nuclear Wastes
Chapter 4: Biotech for Municipal and Countryside Waste Management
Section 4-1: Biotreatment of Sewage System
Section 4-2: Polluted Effluents Bioremediation
Section 4-3: City Waste Water Bioremediation
Section 4-4: Biotechnology for Odor and Air Pollution Control and Quality Control
Section 4-5: Biotreatment for Contaminated Mud and Composting of Garden Plants
Section 4-6: Biotech for Cleansing the Soil of Toxins
Section 4-7: Bioremdiation for City Sludge Ponds
Section 4-8: Biophysico-chemical Remediation Processes of Heavy Metals and Metalloids in Soil
Section 4-9: Microbial System for In Situ Bioremediation of Organic Contaminated Soil and Groundwater
Section 4-10: Microbial Degradation of Pesticides
Section 4-11: Biodegradable of Synthetic Polymers
Section 4-12: Biodegradation of Daily Used Plastics
Section 4-13: Biotechnology for Controlling Air Pollution from Construction Chemicals
Section 4-14: Air Pollution Monitoring and Modeling
Section 4-15: Indoors with Emissions Management
Section 4-16: Sediments, Modeling and Bioprocessing
Section 4-17: Wetlands and Bioremediation
Chapter 5: Biological Treatment Processes of Pollutants
Section 5-1: Water Cleantech: Membrane, Purification & Desalination
Section 5-2: Bioremediation Modeling and Process
Section 5-3: Phytoremediation Modeling and Process
Section 5-4: Biomineralization, Biometallurgy and Biomining
Section 5-5: Algae Photosynthesis in Wastewater Treatment
Section 5-6: Bioavailability, Bioaccumulation Modeling and Process
Section 5-7: Bioaugumentation and Biomagnification Process
Section 5-8: Bioleaching Methods and Application
Section 5-9: Bioremediation or Biodegradation by Subsurface Treatment
Section 5-10: Submerge Aeration Biotreatment
Section 5-11: Surface and Spray Aeration Treatment
Section 5-12: Active Sludge Modeling and Processes
Section 5-13: Pure Oxygen Activated Sludge Processes
Section 5-14: Waste Stabilized Sludge Ponds and Lagoons
Section 5-15: Trickling Filters
Section 5-16: Rotating Biological Contactors
Section 5-17: Sequence Batch Bioreactors
Section 5-18: Oxidation Ditch
Section 5-19: Biological Nitrification and Denitrification Processes
Section 5-20: Anaerobic Digestion and Aerobic Digestion
Section 5-21: Biosolids Compositing
Section 5-22: Vermicompositing Processes
Section 5-23: Biological Oder and VOC Control Processes
Section 5-24: Bioremediation for Air Conditioning Wastes
Section 5-25: Green Manure
Chapter 6: Monitoring Toxins
Section 6-1: Monitoring Biological Indicators and Recovery
Section 6-2: Biomarkers for Environmental Toxin Monitoring
Section 6-3: Molecular and Cell Biology in Environmental Monitoring
Section 6-4: Biosensors for the Environmental Monitoring of Aquatic Systems
Section 6-5: LC-MS for Environmental Toxicology
Section 6-6: Water Pollution Monitoring
Section 6-7: Microbial Monitoring
Section 6-8: ELISA for Environmental Monitoring
Section 6-9: Electronic Microscopy
Section 6-10: Gene Differentiation Technology
Chapter 7: Case Studies of Promising Bio-products and Bio-Methodologies
Section 7-1: Microbial Blend
Section 7-2: Enzymes, Microbial Blends/Enzyme
Section 7-3: Biosurfactants
Section 7-4: Biopolymers
Section 7-5: Nutrients and Micronutrients
Section 7-6: Extremophiles
Section 7-7: Biofertilizer
Section 7-7: Biopesticides and Bioinsectcides
Section 7-9: Biomethanization
Section 7-10: Miscellaneous Functional Biomolecules
Chapter 8: Renewable Energy from Wastes
Section 8-1: Challenges and Opportunities of Bio-waste as Feedstock for Biofuel
Section 8-2: Metabolic Engineering and Synthetic Biology for Waste-to-Bioenergy
Section 8-3: Biomethanization from Organic Municipal Wastes
Section 8-4: Bioenergy from Food Waste and Discarded Vegetable Oil Wastes
Section 8-5: Bioenergy from Livestock Wastes
Section 8-6: Bioenergy from Dairy Products and Bakery Wastes
Section 8-7: Bioenergy from Personal Hygiene Products, Disposable Diapers and Paper Based Packaging
Section 8-8: Bioenergy from Agricultural Wastes
Section 8-9: Biofuel from Forestry Wood Byproducts and Timber Waste
Section 8-10: Biofuel from Aquatic Plants and Manure
Section 8-11: Electricity Generation from Biowaste
Section 8-12: Consolidated Bioprocessing for Waste Conversion to Bioenergy
Chapter 9: Business of Environmental Biotechnology
Section 9-1: Need For Biotechnology In Environmental Management
Section 9-2: Water Pollution, Biotreatment and Water Quality Control
Section 9-3: Industrial Wastewater Biotreatment and Business Development
Section 9-4: Toxic Monitoring Market Outlook
Section 9-5: Technology Licensing, Partnering and Investment
Section 9-6: Novel Product Development and Industrialization
Section 9-7: Environmental Education and Legislative Aspect
Chapter 10: Special Symposium: Environmental Biotechnology meets Petroleum HSE
Section 10-1: HSE and Biotechnology on Oil & Gas Fields
Section 10-2: Characterization of Petroleum Pollutants
Section 10-3: Microbial functions for degradation/transformation of pollutants
Section 10-4: Isolation, Breeding and Genetic Engineering of Pollutants; Degradation Microorganisms
Section 10-5: Microbiology and Hydrocarbon Degradation Microbes
Section 10-6: Bioproducts for Biodegradation of Petroleum Contaminants
Section 10-7: Bioabatement for Petroleum Heavy Metal Removal
Section 10-8: Biotechnology for Reservoir Souring Control
Section 10-9: Biotech for Microbial Induced Corrosion
Section 10-10: Bioremediation for Marine Oil Spill
Section 10-11: Bioremediation of Petroleum Contaminated Soil
Section 10-12: Bioremediation of Petroleum Sludge Ponds
Section 10-13: Biotreatment for Petroleum Contaminated Water
Section 10-14: Grease Trap and Septic Tank Cleaning Products
Section 10-15: Petroleum Biotech for Desulfurization and Denitrogenation
Section 10-16: Bioremediation of Oil Refinery Wastes
Section 10-17: Treatment of Distillation Effluent Wastes
Dear Admin,
please would you delete the real names of persons…
Thank you!
A report from this “scam” can be found on
http://www.bitlifesciences.com/wcmb2011/
Hi all,
I would like to add that I have been receiving similar emails for a cancer-related conference and was happy to come across this site to verify my sense that it wasn’t legitimate – see below:
BIT’s 5th Annual World Congress of Cancer 2012
Theme: Hand-in-Hand for Caring
Time: May 18-20, 2012
Venue: Beijing, China
Website: http://www.bitlifesciences.com/cancer2012/
I’m writing to follow-up my last invitation as below, would you please give me a tentative reply? Thank you very much.
I apologize for the inconvenience if the letter disturbed you more than once. On behalf of the Meeting Organizing Committee, it is my pleasure and privilege to invite you to give a speech at BIT’s 5th Annual World Congress of Cancer 2012 with a theme of Hand-in-Hand for Caring.
BIT Congress is proud to launch the 5th Anniversary of World Cancer Congress (WCC), which will be held from May 18 to May 20, 2012 in Beijing, China
This is an invitation for you to join us in this congress. You can talk about Internet use leads cancer patients to be active health care consumers… at the IT171: Cancer Bioinformatics and Informatics under the Track 1: Breaking Cancer Research and Technology Innovations by submitting your speech title and CV to us. If the suggested thematic session is not your current focused core, you may look through the whole sessions and transfer another one that fit your interest(more info about the congress is available at http://www.bitlifesciences.com/cancer2012/).
This Conference will continue the resounding success of the past conferences in Beijing and will provide a groundbreaking scientific program will draw together many cancer specialists from a wide range of disciplines from all over the world.
Through this international congress it hopes to build upon and develop the great successes already achieved over the past few years. The congress theme of this year is “Hand-in-Hand for Caring” in keeping with the rapid growth and results in cancer research and care throughout the world. The 3-day diverse program has been designed to cover the breadth of oncology from cancer epidemiology and prevention, from drug discovery to cancer treatment and palliative care. It will also cover the main oncological aspects of these themes from molecular biology and genetics, to targeted therapies, innovation technology radiotherapy and imaging.
The program is a very interesting mix of plenary lectures, the technical sessions, educational training courses, practical clinical case as well as industry supported symposia will provide delegates with information on the latest developments in basic science and clinical treatment. Several workshops and posters / papers session will be held concurrently to allow sharing of the excellent experience. The high profile speakers will provide productive form to greatly refresh the participant’s knowledge and experience. Participants will enhance practical knowledge for everyday use and explore the most up-to-date information regarding the treatment of cancer.
Please seize this wonderful opportunity and feel free to participate actively in all areas of the conference, I feel confident that you will enjoy both of the scientific program and the fine, traditional city of Beijing.
To facilitate us to know your further interest, we appreciate your advices on:
1. Focused session and speech titles.
2. What’s your opinion to be the session chair/moderator?
Further info about the program, please visit is available at http://www.bitlifesciences.com/cancer2012/fullprogram.asp
Sincerely yours,
Ms. Sherry Liu
Organizing Committee of World Cancer Congress-2012
East Area, F11, Building 1,
Dalian Ascendas IT Park,
1 Hui Xian Yuan,
Dalian Hi-tech Industrial Zone,
LN 116025, China
Tel: 0086-411-84799609-822
Fax: 0086-411-84799629
Email: sherry@bitlifesciences.com
Track 1: Breaking Cancer Research and Technology Innovations
Section 1-1: Cancer Pathophysiology
CP110: Mechanism of Metastasis and Invasion
CP111: Formation of the Primary Tumor
CP112: Progressive Growth and Angiogenesis
CP113: Transport of Cancer ells
CP114: Oncologic Emergencies
CP115: Environmental Carcinogens
CP116: Identification of Oncogenes and Cancers
Section 1-2: Cancer Biomarkers
CB120: Emerging Technologies for Cancer Biomarker Discovery and Assay
DNA Microarray
CB121: Genomic, Proteomic and Transcriptomic-based Biomarkers in Cancer
CB122: Biomarkers for the Treatment and Progression of Cancers
CB123: Biomarkers for the Prognosis of Cancers
CB124: Methodologies and Applications of Cancer Biomarkers
Section 1-3: Insight into Human Cancers
MC1300: Cancer System Biology
MC1301: Tumor Genetics and Cancer Epigenetics
MS1302: Cancer Genomics, Genomic Instability, and Genome Surveillance
MC1303: Cancer DNA Damage, DNA Repair, and Mitosis
MC1304: Oncogenes, Tumor Suppressors, p53 and Regulation
MC1305: Novel Pathways and Regulations of Cancers
MC1306: Cancer/Tumor Adhesion, Migration, Invasion and Metastasis
MC1307: Tumor Angiogenesis
MC1308: Chromatin Regulation, Telomerase and Cancers
MC1309: Interactions between Host and Tumor
MC1310: Mitochondria and Cancer
MC1311: Cancer Cell Cycle and Check Points
MC1312: Tumor Microenvironment Interactions
MC1313: Cancer Immunomodulation
MC1314: Killing the Tumor Cell
MC1315: Mechanisms of Drug Resistance and Tumor Microenvironment
MC1316: Hematopoietic Growth Factors in Oncology
MC1317: Cancer Profiling
MC1318: Tumor Immunology and Immunotherapy
MC1319: Molecular Pathology and Toxicology of Cancer
Section 1-4: Circulating Tumor Cells
CTC140: Emerging Technologies for CTC-based Cancer Detection
CTC141: Biological and Molecular Characterization of CTCs
CTC142: Molecular Signatures of CTCs
CTC143: CTCs for Cancer Diagnosis, Prognosis and Treatment
CTC144: Clinical Implications of CTCs Analysis on CTC-Tumor Relationship
Section 1-5: Cancer Stem Cells
CSC150: Molecular Biology of Cancer Stem Cells and Clinical Interrelationships
CSC151: The Cancer Stem Cell Niche
CSC152: Reprogramming and Plasticity of Cancer Stem Cells (CSCs)
CSC153: Cancer Stem Cells Signaling Pathways and Implications
CSC154: Breaking Research on Different Cancer Stem Cells
Section 1-6: Metabolism and Cancer
MC160: Studying Metabolism in Model Organism
MC161: Stress Response and Metabolism Involved in Cancer
MC162: Metabolic Influence of Epigenetics on Cancer
MC163: Metabolism and Programmed Cell Death
MC164: Metabolism, ER and Mitochondria
Section 1-7: Innovative Technologies in Cancer Research
IT170: Protein Chips, Tissue Chips, Lab-On-Chip and Microfluidic
IT171: Cancer Bioinformatics and Informatics
IT172: Animal Models and Mathematical Models
IT173: Nanotechnology in Cancer Research
Section 1-8: Translational Oncology
TO180: Tumor Biomarkers in Clinical Trials
TO181: Translation of Cancer Genomes and Integration of Cancer Omics Data
TO182: Personalized Medicine for Cancers
TO183: Developing Rational Strategies for Combination Therapy
TO184: Novel Clinical Trial Design and Companion Diagnostics
Track 2: Tobacco Control and Cancers
TC200: Science, Policy and Public Health on Tobacco Control
TC201: The Growing Tobacco Epidemic, Cancer Risks and Prevention
TC202: Tobacco Carcinogenesis, Pharmacology, Mechanisms and Biomarkers
TC203: Tobacco and Lung Cancer
TC204: Tobacco Control Products and Treatment
Track 3: Anticancer Drug Discovery
-The Search for More Smart Drugs
AD300: New Targets, New Technologies for Anticancer Therapeutics
AD301: Drug Design and Lead Optimization
AD302: High Throughput Screening: Targets, Assays, and Libraries
AD303: Biomarker in Anticancer Drug Discovery
AD304: Pharmacology, ADMET and Anticancer Drug Discover
AD305: Targeting Angiogenesis
AD306: Targeting Cancer Stem Cell Pathway
AD307: Targeting Cell Cycle and Checkpoints
AD308: Targeting DNA Damage Response, DNA Repair, Mitosis and Apoptosis
AD309: Targeting Cancer Epigenetics and The Epigenome
AD310: Targeting Nuclear Serine-Threonine Kinases
AD311: Targeting PI3-Akt-mTOR Pathway and Other Protein Kinases
AD312: Targeting Signaling Pathways and Signal Transduction
AD313: Targeting Ubiquitin-related Pathway
AD314: Targeting Tumor Necrosis Factor (TNF) and Chemokine Receptors
AD315: Targeting Apoptotic Pathways for Novel Therapies in Cancer
AD316: Targeting Wnt Signaling and Hedgehog Signaling Pathways
AD317: Abl and bcr-abl Inhibition
AD318: Telomerase Inhibition
AD319: Inhibition of c-KIT
AD320: Inhibition of Platelet-Derived Growth Factor Receptor (PDGFR) and VEGF
AD321: Next Generation Proteasome Inhibitors
AD322: Anticancer Monoclonal Antibody Discovery
AD323: Anticancer Vaccine and Novel Adjuvant Approaches
AD324: Gene Therapy, and RNAi based Anticancer Drug Discovery
AD325: Anticancer Drug Discovery by Inhibition of Stem Cell Signaling
AD326: Design New Molecules to Surpass Anticancer Drug Resistance
AD327: Aurora Kinases and Their Inhibitors
AD328: BRAF Targeted Therapy of Melanoma
AD329: Targeting Cell Surface Proteins/Apoptosis
AD330: Targeting Tumor Stroma Interaction
AD331: T-Cell Therapies for Cancers
AD332: Targeted Hormonal Therapies
AD333: Targeting Tumor Metabolism
AD334: Novel Cancer Drug Delivery Systems
AD335: Update on Clinical Trials on Anticancer Therapeutics
Track 4: Professional Networking Program
PN 400: Meet-the-Expert-Tumor Biologists
PN 401: Meet-the Expert-Tumor Immunologiests
PN 402: Meet-the-Expert: Clinical Oncologists
PN 403: Meet-the-Expert: Oncological Computation Experts
PN 404: Meeting with Pioneers: Distinguished Leading Scientists
PN 405: Meeting with Future Mentors: Learning the Graduate Study Programs
PN 406: Meeting with Editors: How to Publish Your Research Results?
PN 407: Meeting with Fund Managers: How to Write Your Successful Grant?
PN408: Meeting with Successful CEOs: How to Succeed in Your Entrepreneurship
PN 409: Career Advancement Tracks: Job Listing from Academia and Industries
Track 5: Clinical Oncology and Medical Practice
Section 5-1: Diagnosis and Prognosis of Cancers
DP510: Imaging to Detect Recurrent Cancer
DP511: Blood tests, Cancer Biomarkers for Molecular Diagnosis
DP512: Proteomic Profiling for Cancer Diagnosis
DP513: Real-time PCR and Amplification of Other Technologies
DP514: Imaging and Diagnosis: X-Rays, MRI and MRCP, CT Scanning, PET and Ultrasound
Section 5-2: Clinical Research on Cancers
CT5200: Practical Cancer Chemotherapy
CT5201: Radiotherapy and Medical Device Therapy for Cancer
CT5202: Hormone Therapy in Cancer
CT5203: Pharmacogenomics and Personalized Medicine
CT5204: Sirtuins, Obesity, and Cancer
CT5205: Cancer Surgery, and Symptom Management
CT5206: Robotics and Tumor Mini-invasive Therapy
CT5207: Botanical Medicine for Cancers in Clinical Practice
CT5208: Integrative Medicine and Interventional Methods in Oncology
CT5209: Systemic Treatment for Cancer
CT5210: Clinical Development of Epidermal Growth Factor Receptor (EGFR)
CT5211: Tyrosine Kinase Inhibitors: What Lessons Have We Learned?
Section 5-3: Case Analysis on Diversified Cancers/Solid Tumors
CR5300: Lung and Mediastinum Cancers
CR5301: Breast Cancer
CR5302: Esophageal/Stomach Cancer
CR5303: Prostate Cancer
CR5304: Colorectal Cancer, Colon, Rectal and Anal Cancer Management
CR5305: Melanoma and Non-melanoma Skin Cancers
CR5306: Kidney Cancer, Renal Cell Cancer and Adrenal Cancers
CR5307: Head and Neck Cancers: Nasopharyngeal, Oral Cavity Cancers
CR5308: Hematologic Malignancies
CR5309: Bone, Sarcoma Cancers and Soft Tissue Cancers
CR5310: Overian, Cervical, Vulva, Vagina, Uterine Malignancies and Endometrial
Cancers
CR5311: Neuroendocrine, CNS Tumors and Glioblastoma
Section 5-4: Cancer Nursing and Support Care
CN540: Oncology Nursing and Clinical Pain Management
CN541: Palliative Care and Psycho-Oncology
CN542: Quality of Life in Long-term Cancer Survivors
CN543: Cancer Survivorship Research
Track 6: Cancer Prevention, Epidemiology, and Public Health
CP600: Cancer Genetics, Epidemiology, Biostatistics and Prevention
CP601: Cancer Screening , Monitoring, and Counseling for High-Risk Populations
CP602: Food Carcinogen and Safety Control in Public Health
CP603: Cancer Rehabilitation, Nutrition and Complementary Therapy
CP604: Environment and Breast Cancer
I do not think these conferences are a scam. Rather, these are commercial enterprises trying to make money off participants by abnormally high registration fees and probably selling overpriced tours. Nothing wrong with that if it would be possible to opt out of their emails.
Has anyone had a paper solicited by:
7th CJB International Conference on Biotechnology and Science 2012, to be held on Sept 12-14th, 2012 at the Grosvenor House, JW Marriot, London? What they are offering seems too good to be true, with their available grants. Their website is http://www.icbs2012.cjb.net
Thanks so much for any reply!!
Just got invited to http://www.bitconferences.com/mts2012/default.asp.
The first thing that made me suspicious was the unreasonably big complements they give you in their email. Another fishy thing I noticed was that they had no reputable sponsors, and no well-known names in the committee. And the registration fees were of course ridiculously high, this taken into account. While these guys ask for 2000USD, reputable IEEE conferences ask for 1000USD. So after a few Google searches I found http://www.oceanographerschoice.com/2010/09/phishy-conference/.
I don’t doubt that this is some kind of scam, but I’m quite impressed by the amount of work they have laid down into it.
They are really involved in all fields of science, and probably have real scientists involved because it is quite accurate. I was pretty sure it was a scam and thus googled it, and came up here. I wonder how they find scientists. Any ideas? Web of science? University websites?
—
Dear Dr.**** ******* ,
How are you doing now?
I am Maya, the Program Coordinator of 2nd Annual International Symposia of Mycology (ISM-2012), I am writing the letter to make sure if you have received my letter previously, it is about the conference: ISM-2012 which will be held on July 30 to August 1, 2012 in Guangzhou, China.
Based upon your great contributions to this particular field, we’d like to invite you to deliver an oral presentation at ISM 4-1: Fungal Ecology, Diversity and Metabolites The details of the sessions are:
ISM-1: Basic Research on Mycology
ISM 1-1: Breaking R & D in Molecular Mycology
ISM 1-2: Molecular Biology of Pathogenic Fungi
ISM 1-3: Fungal Genetics and Genomics
ISM 1-4: Fungal Metabolomics, Transcriptomics and Proteomics
ISM 1-5: Medical and Veterinary Mycology
ISM 1-6: Biological Control of Fungi
ISM 1-7: Plant Pathogenic Fungi
ISM 1-8: Fungal Distribution and Diversity
ISM -2: Antifungal Drug Discovery
ISM -3: Fungal Disease, Diagnosis and Clinical Management
ISM 3-1: Clinical Mycology and Human Mycoses
ISM 3-2: Systematic Fungal Infection and Treatment
ISM 3-3: Diagnosis to Prevention of Aspergillosis Infection
ISM 3-4: Mycology involving Skin and Subcutaneous Tissues
ISM 3-5: Clinical Perspectives of Invasive Fungal Infections
ISM 3-6: Nosocomial Fungal Infections
ISM 3-7: Clinical Management of Severe Fungal Infection
ISM -4: Fungal Biotechnology
ISM 4-1: Fungal Ecology, Diversity and Metabolites
ISM 4-2: Fungal Resistant Crops
ISM 4-3: Fungi in Weed Control
ISM 4-4: Antibiotics, Enzymes and Chemical Commodities from Fungi
ISM 4-5: Pigments from Fungi
ISM 4-6: Yeast Fermentation and Fungi in Brewing Processes
ISM 4-7: Natural Products and Manufacturing from Fungi
ISM 4-8: Fungi in Environmental Bioremediatio
For the program details: http://www.bitlifesciences.com/wcm2012/fullprogram_ism.asp
If it is not of interest to you, please disregard and we apologize for any inconvenience this may have caused. To prevent further emails, go to http://www.bitcongress.com/Unsubscribe.asp
Sincerely Yours,
Ms. Maya Chen
Program Coordinator
Organizing Committee of ISM-2012, China
East Wing, 11F,
Dalian Ascendas IT Park
No. 1 Hui Xian Yuan,
Dalian Hi-tech Industrial Zone
LN 116025, P.R.China
Tel: 0086-411-84799609-813
Fax: 0086-411-84799629
Email: maya@bitconferences.com
I too have been contacted by this BIT’s World Cancer Conference many times. Although I am invited, I assume that I’ll need to register and pay for all fee. It’s quite common these days for them to do that. A few days ago I got another letter and I am genuinely interested since I have never been to Beijing before. I contacted them and I asked if I could pay on site since it is written in their website. They replied that I could not because they wanted to make sure all the speakers would show up, which is reasonable. I then told them to cancel my talk because my school would not support that exceedingly expensive fee. They offered me $400 discount. I am not saying that they are not legitimate. But it is really phishy. On their website, the last conference had only 400 participants. With all those big name professors, that doesn’t sound right.
Hi Folks,
These conferences are legitimate. I attended one last year and it was well organized – all the eminent people (incl Nobel Prize Winner) advertised were there and presented interesting talks and there was no scam or credit card fraud. Yes, the way that they approach speakers is not the way that it is done in the USA or Europe. But perhaps you should be a bit more open to the extraordinary opportunities in China rather taking such a dismissive tone. The science capacity and investment in China is immense and engaging with that rather than libelling the organizers of a conference because it is differnet might be a better strategy. For sure not every scientific innovation will come out of the western world in the future.
Just my small contribution to correcting the record and one based on first hand experience!
Regards,
Dave Green